Vaccine

COVID-19: World's poorest must not be 'trampled' in vaccine race - WHO

• 15 hours   ago
• Updates

AstraZeneca vaccine can be up to 90% effective; COVID-19 reinfection unlikely for at least six months

• 15 hours   ago
• Updates

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for

Saudi Health Ministry to make coronavirus vaccine free for citizens and residents

• 15 hours   ago
• Updates

The Saudi Ministry of Health is aiming to offer free vaccines to 70 percent of citizens and expats in the Kingdom who have not yet contracted the

Spain to begin vaccination programme in January, Sanchez says

• 2 days   ago
• Updates

Spain will begin a comprehensive coronavirus vaccination programme in January and expects to have covered a substantial part of the population

Pfizer COVID-19 vaccine could get UK approval this week

• 2 days   ago
• Updates

Britain could give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the United States authorises it, the

Moderna to charge $25-$37 for COVID-19 vaccine

• 3 days   ago
• Updates

REUTERS
Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered,

G20 leaders pledge to fund fair distribution of COVID-19 vaccines

• 3 days   ago
• Updates

REUTERS
Leaders of the world’s 20 biggest economies on Sunday will pledge to pay for a fair distribution of COVID-19 vaccines,

Siberian-made EpiVacCorona Covid-19 vaccine creates antibodies in 100% of participants in initial small-scale trial

• 3 days   ago
• Updates

All volunteers vaccinated by Siberia’s Vector Research Center’s EpiVacCorona coronavirus formula have developed antibodies. The

Childhood vaccine linked to less severe COVID-19, cigarette smoke raises risk

• 4 days   ago
• Updates

REUTERS
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and

Canada expects six million COVID-19 vaccine doses early in 2021

• 4 days   ago
• Updates

Canada expects to receive six million doses of COVID-19 vaccines by March 31, 2021 under existing purchase contracts, but their use depends on

India: Oxford Vaccine Likely By April 2021, ₹ 1,000 For 2 Doses: Adar Poonawalla

• 4 days   ago
• Updates

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare

Turkey to buy Chinese COVID-19 candidate vaccine doses, in talks with Pfizer

• 5 days   ago
• International

REUTERS
Turkey will sign a contract within days to buy at least 20 million doses of a COVID-19 candidate vaccine from China’s

Brazil will not exempt COVID-19 vaccine makers from liability, deputy minister says

• 5 days   ago
• Updates

Brazil does not intend to draw up legislation that would exempt makers of COVID-19 vaccines from liability, the country’s deputy health

EU warns Hungary against use of Russia's COVID-19 vaccine

• 5 days   ago
• Updates

REUTERS
Hungary’s plans to import and possibly use Russia’s touted Sputnik V COVID-19 vaccine raise safety concerns and

AstraZeneca COVID-19 vaccine shows promise in elderly, trial results by Christmas

• 5 days   ago
• Updates

REUTERS
AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data

Covid: Oxford vaccine shows 'encouraging' immune response in older adults

• 5 days   ago
• Updates

The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged

Covid-19 vaccine is proving effective; enable life to return to normal sooner than later: Dr Khal

• 6 days   ago
• Local

The Ministry of Public Health’s proactive approach to secure COVID-19 vaccine from various sources has proven effective, Dr Abdullatif Al

Pfizer, Moderna COVID-19 vaccines may be authorized for use within weeks

• 6 days   ago
• Updates

REUTERS
COVID-19 vaccines from Pfizer Inc and Moderna Inc could be ready for U.S. authorization and distribution within weeks, setting

COVID-19 survivors may have long lasting immunity; Pfizer vaccine is 95% effective in trial

• 6 days   ago
• Updates

REUTERS
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and